NexImmune, Inc.

NexImmune, Inc. financial statements

NexImmune, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2023

RevenueUSD 0EODHD
Net income−USD 32.34MEODHD
Cash and equivalentsUSD 3.2MEODHD
Total debtUSD 68.81KEODHD

NexImmune, Inc. financials on 6ix · NexImmune, Inc. on 6ix